Bullish
$PRVB And why is 200/share completely reasonable as stated below by @microcapspeculator ? The drug prevented (not delayed) type 1 D in 57% of the patient population with one 14 day dose. A second dose, or booster, will even further the drug's success. We have the tiger by the tail. ๐Ÿ‘Š
  • 11
  • 11